PHECG2

Chief Investigator: Prof. Tom Quinn, Kingston University and St George’s University of London

Summary

Use and impact of the pre-hospital 12-lead electrocardiogram in the primary PCI era: Mixed method study (PHECG-2)

Funder: British Heart Foundation

 

The Pre-Hospital 12-lead ElectroCardioGram (PHECG) is a simple test that helps ambulance clinicians assess patients with suspected acute coronary syndrome (heart attack), and provides clinical data to inform ongoing care. This project builds on previous work by this team, which found that one in three eligible patients did not receive a PHECG, but those that did had a lowered risk of short-term death. In this study we will update that work, and explore reasons for variations in practice -highlighting opportunities to improve care and outcomes.

Using routinely collected data and qualitative methods, we will research patient, practitioner and contextual contributing to the decision to administer a PHECG. We will aim to develop an intervention to increase the proportion of eligible patients that receive a PHECG, and to produce a proposal for further funding to test this intervention in a subsequent randomised trial.


Contact Details

Trial Manager / Lead Contact: Lucia Gavalova
Email: PHECG2study@sgul.kingston.ac.uk

Eudra CT Number: NCT03699137; IRAS ID: 248748;